A Trial to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD

Clinical trial NCT06619210 · COMPLETED

Trial details

NCT number: NCT06619210
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2022-01-12
Primary completion: 2023-05-29
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.